China Medical System Holdings (HKSE:00867) Additional Paid-In Capital : HK$2,303 Mil(As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Additional Paid-In Capital?

China Medical System Holdings's quarterly additional paid-in capital declined from Dec. 2022 (HK$2,351 Mil) to Jun. 2023 (HK$2,303 Mil) but then stayed the same from Jun. 2023 (HK$2,303 Mil) to Dec. 2023 (HK$2,303 Mil).

China Medical System Holdings's annual additional paid-in capital increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$2,351 Mil) but then declined from Dec. 2022 (HK$2,351 Mil) to Dec. 2023 (HK$2,303 Mil).

China Medical System Holdings Additional Paid-In Capital Historical Data

The historical data trend for China Medical System Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Additional Paid-In Capital Chart

China Medical System Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

2,351.38

2,303.08

China Medical System Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															-	-	2,351.38	2,303.09	2,303.08

China Medical System Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

China Medical System Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

China Medical System Holdings (HKSE:00867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

2M7C:Germany

Address

510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG

Website

http://www.cms.net.cn

China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

Executives

Treasure Sea Limited	2101 Beneficial owner
Lam Kong	2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines